The Goldman Sachs Group, Inc. 13D and 13G filings for Silence Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 6:15 pm Sale |
2023-12-29 | 13G | Silence Therapeutics plc SLN |
GOLDMAN SACHS GROUP INC GS |
2,316,169 2.200% |
-2,224,994 (-49.00%) |
Filing |
| 2023-02-08 3:09 pm Purchase |
2022-12-30 | 13G | Silence Therapeutics plc SLN |
GOLDMAN SACHS GROUP INC GS |
4,541,163 5.100% |
4,541,163 (New Position) |
Filing |